Arrayit Stock Today

ARYC Stock  USD 0.0001  0.00  0.00%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

High

 
High
 
Low
Arrayit is trading at 1.0E-4 as of the 6th of February 2026, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Arrayit has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 8th of November 2025 and ending today, the 6th of February 2026. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company has 1.13 B outstanding shares. More on Arrayit

Arrayit Stock Highlights

Chairman, CEO and CFORene Schena
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover2.613.94
Way Down
Very volatile
Gross Profit Margin0.560.53
Notably Up
Slightly volatile
Total Current Liabilities6.3 M6.7 M
Significantly Down
Slightly volatile
Total Assets989.9 K1.2 M
Fairly Down
Slightly volatile
Total Current Assets845.5 K834.6 K
Fairly Up
Pretty Stable
Arrayit (ARYC) is traded on OTCCE Exchange in USA and employs 7 people. Arrayit is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 112.65 K. Arrayit conducts business under Biotechnology sector and is part of Health Care industry. The entity has 1.13 B outstanding shares. Arrayit currently holds about 58.76 K in cash with (749.72 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Arrayit Probability Of Bankruptcy
Ownership Allocation
Arrayit holds a total of 1.13 Billion outstanding shares. Arrayit shows 14.8 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Arrayit Ownership Details

Arrayit Historical Income Statement

As of February 6, 2026, Selling General Administrative is expected to decline to about 2.9 M. In addition to that, Total Revenue is expected to decline to about 3.7 M View More Fundamentals

Arrayit Stock Against Markets

Already Invested in Arrayit?

The danger of trading Arrayit is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arrayit is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arrayit. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arrayit is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Arrayit offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arrayit's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arrayit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arrayit Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrayit. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For information on how to trade Arrayit Stock refer to our How to Trade Arrayit Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Biotechnology sector continue expanding? Could Arrayit diversify its offerings? Factors like these will boost the valuation of Arrayit. If investors know Arrayit will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Arrayit data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Revenue Per Share
0.015
Quarterly Revenue Growth
0.249
Return On Assets
(2.10)
The market value of Arrayit is measured differently than its book value, which is the value of Arrayit that is recorded on the company's balance sheet. Investors also form their own opinion of Arrayit's value that differs from its market value or its book value, called intrinsic value, which is Arrayit's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Arrayit's market value can be influenced by many factors that don't directly affect Arrayit's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Arrayit's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Arrayit represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Arrayit's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.